BMTM · Bright Mountain Media, Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“The Company's current cash and working capital, as of the filing of this Quarterly Report on Form 10-Q, are not expected to be sufficient to fund its anticipated level of operations over the next twelve months. As a result, such matters create a substantial doubt regarding the Company's ability to meet its financial obligations and continue as a going concern.”View the 10-Q filed Aug 6, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-06 | Olgun Ari Roy |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options shall vest and become exercisable in four equal annual installments on May 6, 2027, May 6, 2028, May 6, 2029, and May 6, 2030. |
Stock Option (right to buy)
|
1,000,000 |
| 2026-02-26 | PERGOLA JOSEPH |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options shall vest and become exercisable on December 31, 2026; provided, however, that in the event the Reporting Person resigns as a member of the Issuer's Board of Directors without cause during 2026, the number of shares underlying the stock option shall be prorated through the date of resignation and shall vest on the date of the Reporting Person's resignation. |
Stock Option (right to buy)
|
100,000 |
| 2026-02-26 | Riddell Elaine J. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options shall vest and become exercisable on December 31, 2026; provided, however, that in the event the Reporting Person resigns as a member of the Issuer's Board of Directors without cause during 2026, the number of shares underlying the stock option shall be prorated through the date of resignation and shall vest on the date of the Reporting Person's resignation. |
Stock Option (right to buy)
|
100,000 |
| 2026-02-26 | Triscari Thomas A. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options shall vest and become exercisable on December 31, 2026; provided, however, that in the event the Reporting Person resigns as a member of the Issuer's Board of Directors without cause during 2026, the number of shares underlying the stock option shall be prorated through the date of resignation and shall vest on the date of the Reporting Person's resignation. |
Stock Option (right to buy)
|
100,000 |
| 2026-02-26 | Hirsch Jeffrey K. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options shall vest and become exercisable on December 31, 2026; provided, however, that in the event the Reporting Person resigns as a member of the Issuer's Board of Directors without cause during 2026, the number of shares underlying the stock option shall be prorated through the date of resignation and shall vest on the date of the Reporting Person's resignation. |
Stock Option (right to buy)
|
100,000 |
| 2025-12-10 | Drinkwater Matthew |
Director, Chief Executive Officer |
Other↑
Filing footnotes — Common Stock (Direct)
Small acquisition eligible for deferred reporting pursuant to Rule 16a-6 under the Securities Exchange Act of 1934. |
Common Stock
|
299,500 |
| 2025-03-07 | Rudin Ethan |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options shall vest and become exercisable in four equal annual installments on March 7, 2026, March 7, 2027, March 7, 2028, and March 7, 2029. |
Stock Option (right to buy)
|
125,000 |
| 2025-01-02 | Triscari Thomas A. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options shall vest and become exercisable on December 31, 2025; provided, however, that in the event the Reporting Person resigns as a member of the Issuer's Board of Directors without cause during 2025, the number of shares underlying the stock option shall be prorated through the date of resignation and shall vest on the date of the Reporting Person's resignation. |
Stock Option (right to buy)
|
100,000 |
| 2025-01-02 | Riddell Elaine J. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options shall vest and become exercisable on December 31, 2025; provided, however, that in the event the Reporting Person resigns as a member of the Issuer's Board of Directors without cause during 2025, the number of shares underlying the stock option shall be prorated through the date of resignation and shall vest on the date of the Reporting Person's resignation. |
Stock Option (right to buy)
|
100,000 |
| 2025-01-02 | Hirsch Jeffrey K. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options shall vest and become exercisable on December 31, 2025; provided, however, that in the event the Reporting Person resigns as a member of the Issuer's Board of Directors without cause during 2025, the number of shares underlying the stock option shall be prorated through the date of resignation and shall vest on the date of the Reporting Person's resignation. |
Stock Option (right to buy)
|
100,000 |
| 2025-01-02 | PERGOLA JOSEPH |
Director |
Award↑
Filing footnotes — Stock Option (right to buy (Direct)
The stock options shall vest and become exercisable on December 31, 2025; provided, however, that in the event the Reporting Person resigns as a member of the Issuer's Board of Directors without cause during 2025, the number of shares underlying the stock option shall be prorated through the date of resignation and shall vest on the date of the Reporting Person's resignation. |
Stock Option (right to buy
|
100,000 |
| 2024-11-14 | Drinkwater Matthew |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option vests in four equal annual installments on November 14, 2025, November 14, 2026, November 14, 2027, and November 14, 2028. |
Stock Option (right to buy)
|
125,000 |
| 2024-09-11 | Drinkwater Matthew |
Director, Chief Executive Officer |
Other↑
Filing footnotes — Common Stock (Direct)
Small acquisition eligible for deferred reporting pursuant to Rule 16a-6 under the Securities Exchange Act of 1934. |
Common Stock
|
3,000 |
| 2024-09-06 | Drinkwater Matthew |
Director, Chief Executive Officer |
Other↑
Filing footnotes — Common Stock (Direct)
Small acquisition eligible for deferred reporting pursuant to Rule 16a-6 under the Securities Exchange Act of 1934. |
Common Stock
|
3,000 |
| 2024-08-20 | Drinkwater Matthew |
Director, Chief Executive Officer |
Other↑
Filing footnotes — Common Stock (Direct)
Small acquisition eligible for deferred reporting pursuant to Rule 16a-6 under the Securities Exchange Act of 1934. |
Common Stock
|
14,432 |
| 2024-08-08 | Triscari Thomas A. |
Director |
Award↑
|
Stock Option (right to buy)
|
39,891 |
| 2024-08-08 | Riddell Elaine J. |
Director |
Award↑
|
Stock Option (right to buy)
|
39,891 |
| 2024-08-08 | PERGOLA JOSEPH |
Director |
Award↑
|
Stock Option (right to buy)
|
39,891 |
| 2024-03-26 | Hirsch Jeffrey K. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of the Issuer's common stock granted under the Issuer's director compensation policy for services provided for the period from August 15, 2023 through December 31, 2023. |
Common Stock
|
38,082 |
| 2024-01-01 | Hirsch Jeffrey K. |
Director |
Award↑
|
Stock Option (right to buy)
|
100,000 |
| 2023-10-18 | Rudin Ethan |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option vests in four equal annual installments on October 18, 2024, October 18, 2025, October 18, 2026 and October 18, 2027. |
Stock Option (right to buy)
|
325,000 |
| 2022-05-26 | Drinkwater Matthew |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Of the shares underlying the stock option, 125,000 shares are fully vested. The remaining shares shall vest and become exercisable in two equal installments on May 26, 2025 and May 26, 2026. |
Stock Option (right to buy)
|
250,000 |
| 2021-12-01 | Drinkwater Matthew |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Of the shares underlying the stock option, 375,000 shares are fully vested. The remaining shares shall vest and become exercisable on December 1, 2024. |
Stock Option (right to buy)
|
500,000 |
| 2020-12-29 | SPEYER W KIP |
Director, Chairman & CEO, 10% Owner |
Gift↓
|
Common Stock
|
125,000 |
| 2020-03-20 | SPEYER W KIP |
Director, Chairman & CEO, 10% Owner |
Buy↑
|
Common stock
|
2,100 |